These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 10434233)

  • 1. Comparison of the pharmacokinetics of 17 beta-estradiol after a single 4-day application of Oesclim 50, Oesclim 100, and Vivelle 0.05 (Menorest 50) transdermal delivery systems.
    Guichard JP; Sauron R; Jones AB
    J Clin Pharmacol; 1999 Aug; 39(8):811-6. PubMed ID: 10434233
    [TBL] [Abstract][Full Text] [Related]  

  • 2. OESCLIM: an advanced delivery system for HRT.
    Munoz A
    Maturitas; 1999 Nov; 33 Suppl 1():S39-47. PubMed ID: 10661614
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of two estradiol transdermal systems (Oesclim 50 and Estraderm TTS 50). I. Tolerability, adhesion and efficacy.
    Rozenbaum H; Birkhäuser M; De Nooyer C; Lambotte R; Pornel B; Schneider H; Studd J
    Maturitas; 1996 Nov; 25(3):161-73. PubMed ID: 8981333
    [TBL] [Abstract][Full Text] [Related]  

  • 4. 17Beta-estradiol delivered by three different matrix patches 50 microg/day: a three way cross-over study in 21 postmenopausal women.
    Rohr UD; Nauert C; Stehle B
    Maturitas; 1999 Sep; 33(1):45-58. PubMed ID: 10585173
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparative bioequivalence studies with Estradot and Menorest transdermal systems.
    Hossain M; Quebe-Fehling E; Sergejew T; Schmidt G; Skerjanec A; Cohen A; Krinsky L; Ibarra de Palacios P
    Maturitas; 2003 Nov; 46(3):187-98. PubMed ID: 14585521
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of two estradiol transdermal systems (Oesclim 50 and Estraderm TTS 50). II. Local skin tolerability.
    Rozenbaum H; Birkhäuser M; De Nooyer C; Lambotte R; Pornel B; Schneider H; Studd J; Thebault J
    Maturitas; 1996 Nov; 25(3):175-85. PubMed ID: 8981334
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bioavailability of estradiol from two matrix transdermal delivery systems: Menorest and Climara.
    Andersson TL; Stehle B; Davidsson B; Höglund P
    Maturitas; 2000 Jan; 34(1):57-64. PubMed ID: 10687883
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Characterization of a 7 day 17 beta-estradiol transdermal delivery system: pharmacokinetics in healthy postmenopausal women.
    Boyd RA; Zegarac EA; Eldon MA; Sedman AJ; Forgue ST
    Biopharm Drug Dispos; 1996 Aug; 17(6):459-70. PubMed ID: 8866037
    [TBL] [Abstract][Full Text] [Related]  

  • 9. OESCLIM: pre-clinical and clinical profile.
    Guy M
    Maturitas; 1999 Nov; 33 Suppl 1():S49-55. PubMed ID: 10661615
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacokinetics of a 7-day 17 beta-estradiol transdermal delivery system: effect of application site and repeated applications on serum concentrations of estradiol and estrone.
    Boyd RA; Yang BB; Abel RB; Eldon MA; Sedman AJ; Forgue ST
    J Clin Pharmacol; 1996 Nov; 36(11):998-1005. PubMed ID: 8973988
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficacy and tolerability of low-dose transdermal estrogen (Oesclim) in the treatment of menopausal symptoms.
    Gadomska H; Barcz E; Cyganek A; Leocmach Y; Chadha-Boreham H; Marianowski L
    Curr Med Res Opin; 2002; 18(2):97-102. PubMed ID: 12017217
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficacy and tolerability of Menorest 50 compared with Estraderm TTS 50 in the treatment of postmenopausal symptoms. A randomized, multicenter, parallel group study.
    Pornel B; Genazzani AR; Costes D; Dain MP; Lelann L; Vandepol C
    Maturitas; 1995 Nov; 22(3):207-18. PubMed ID: 8746878
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Steady-state bioavailability of estradiol from two matrix transdermal delivery systems, Alora and Climara.
    Buch A; Shen L; Kelly S; Sahota R; Brezovic C; Bixler C; Powell J
    Menopause; 1998; 5(2):107-12. PubMed ID: 9689205
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Plasma estradiol concentrations and pharmacokinetics following transdermal application of Menorest 50 or Systen (Evorel) 50.
    Reginster JY; Albert A; Deroisy R; Colette J; Vrijens B; Blacker C; Brion N; Caulin F; Mayolle C; Regnard A; Scholler R; Franchimont P
    Maturitas; 1997 Jun; 27(2):179-86. PubMed ID: 9255753
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacokinetics of estradiol and of estrone during application of a new 7-day estradiol transdermal patch with active matrix.
    Setnikar I; Rovati LC; Vens-Cappell B; Hilgenstock C
    Arzneimittelforschung; 1998 Mar; 48(3):275-85. PubMed ID: 9553686
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficacy and tolerability of a low-dose of Oesclim (25 mcg daily) in the management of symptomatic menopausal women: a French open-label study.
    Elia D; Tamborini A; Leocmach Y; Chadha-Boreham H
    Curr Med Res Opin; 2000; 16(2):94-106. PubMed ID: 10893653
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacokinetics of continuous once-a-week combination 17β-Estradiol/Low- or high-dose levonorgestrel transdermal delivery systems in postmenopausal women.
    Karara AH; Harrison LI; Melikian AP; Poola N; Morrison D; Bourg D; Bourg L; Zurth C
    J Clin Pharmacol; 2014 May; 54(5):520-7. PubMed ID: 24474034
    [TBL] [Abstract][Full Text] [Related]  

  • 18. OESCLIM: summary of tolerability and safety.
    Brackman F
    Maturitas; 1999 Nov; 33 Suppl 1():S83-8. PubMed ID: 10661619
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The effect of site of application on the transcutaneous absorption of 17-beta estradiol from a transdermal delivery system (Climara).
    Taggart W; Dandekar K; Ellman H; Notelovitz M
    Menopause; 2000; 7(5):364-9. PubMed ID: 10993035
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of the efficacy and tolerability of a new once-a-week matricial estradiol transdermal system (Estrapatch 40 and Estrapatch 60) with a twice week system.
    Raynaud JP; Lévrier M; Calaf J; Laur C; Pélissier C
    J Steroid Biochem Mol Biol; 2005 Feb; 93(2-5):309-18. PubMed ID: 15860275
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.